Authors
Loading...
Preclinical study demonstrates selective target protein degradation in leukemic mice, indicating a chemical strategy to pharmacologically target previously undruggable transcription factors.
Winter et al. (2015) studied this question.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: